Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001415889-25-003167
Filing Date
2025-02-05
Accepted
2025-02-05 20:09:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 34036
  Complete submission text file 0001415889-25-003167.txt   35789
Mailing Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850
Business Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850 (301) 670 2800
I-Mab (Subject) CIK: 0001778016 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-91674 | Film No.: 25595050
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SUITE 3306-3307, TWO EXCHANGE SQUARE 8 CONNAUGHT PLACE CENTRAL, HONG KONG F4 00000
Business Address SUITE 3306-3307, TWO EXCHANGE SQUARE 8 CONNAUGHT PLACE CENTRAL, HONG KONG F4 00000 8621 8012 1275
CBC Investment I-Mab Ltd (Filed by) CIK: 0001845246 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SCHEDULE 13D